vivo use radioiodinated somatostatin analogue dynamics metabolism receptor-positive tumors man Somatostatin gamma-emitting radionuclides potential value localization somatostatin receptor-positive tumors gamma camera imaging application man radioiodinated analogue somatostatin similar biologic characteristics native peptide radiopharmaceutical circulation dose min liver Liver radioactivity biliary system hr injection radioactivity circulation form Thereafter plasma samples proportions free iodide first hours injection radioactivity urine form unchanged peptide Thereafter progressive increase radioiodide excretion degradation radiopharmaceutical vivo Fecal excretion radioactivity amounts percent dose calculated median effective dose equivalent comparable values applications mSv/MBq 